Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Dube Michael P
VP, Chief Accounting Officer at Intellia Therapeutics. Filing since 2 Oct 2024.
CIK 0002019493
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
2 Oct 2026
VP, Chief Accounting Officer
Sold at will
1,864
$23.17K
2.8%
NTLA
Intellia Therapeutics, Inc.
1 Jul 2026
VP, Chief Accounting Officer
Sold at will
2,641
$44.32K
3.8%
NTLA
Intellia Therapeutics, Inc.
5 Jan 2026
VP, Chief Accounting Officer
Sold at will
2,989
$27.53K
5.4%
NTLA
Intellia Therapeutics, Inc.
1 Oct 2025
VP, Chief Accounting Officer
Sold at will
1,871
$32.52K
3.3%
NTLA
Intellia Therapeutics, Inc.
2 Jul 2025
VP, Chief Accounting Officer
Sold at will
2,503
$24.90K
4.2%
NTLA
Intellia Therapeutics, Inc.
3 Jan 2025
VP, Chief Accounting Officer
Sold at will
1,372
$16.71K
2.9%
NTLA
Intellia Therapeutics, Inc.
2 Oct 2024
VP, Chief Accounting Officer
Sold at will
2,012
$38.25K
4.1%
7 decisions on file.
